Fingerprint
Dive into the research topics of 'Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab
Konstantinos A. Papadakis, Omid A. Shaye, Eric A. Vasiliauskas, Andrew Ippoliti, Marla C. Dubinsky, Jaime Birt, Jane Paavola, Susie K. Lee, Joanne Price, Stephan R. Targan, Maria T. Abreu
Research output: Contribution to journal › Article › peer-review
160
Scopus
citations